News Snapshot:
4 minutes ago | By After months of intense negotiations, vaccine maker Moderna is nearing an agreement to pledge many millions more doses of its Covid-19 shot to low- and middle-income countries in 2022, two people with knowledge of the matter told POLITICO. The deal with chief vaccine equity initiative COVAX would provide a boost to a global vaccination campaign that has suffered from delays and difficulties in securing sufficient doses from drug makers. It comes amid escalating pressure on Moderna - which has benefited from U.S. taxpayer-funded vaccine technology without a requirement to share it with... Read more ......
